The sale price includes 4 open and operating units in Los Angeles. The sale price also includes the fully built-out centers, plus equipment and inventory. Also included are the rights to build 16 additional units. The current owner is running this semi-passively, but a new hands-on owner is needed to take this to the next level. The clinics offer various tailored treatment plans for damaged joints, muscles, tendons, ligaments, cartilage, and tissue due to arthritis or injury. This is an all-cash business, and we do not accept insurance. The clinics use non-surgical injections to restore damaged tissue, decrease pain, and increase quality of life. This is designed to be a long-term fix and keep patients out of surgery, away from toxic steroid injections, and off addictive pain medications. The new owner will be working alongside a team of professionals. The team consists of the following roles:
Medical provider (nurse practitioner).
Medical assistant.
Front desk reception.
The new owner will not be required to have prior medical training or experience. The ideal new owner will have a strong management background. The regenerative medicine and stem cell therapy market is estimated to be currently valued at 13.3 billion and projected to reach 38.7 billion by 2024. The cell-based immunotherapy and cell therapy products segment accounted for the largest market share in 2019. This is the perfect business for a qualified operator looking to join a first-class, established franchise system and to compress time by purchasing a protected, multi-unit territory.
Other Important Business Attributes Include:
Semi-absentee or Owner Operator
limited Limited Competition.
All Cash Clinics. There are no insurance companies.
The Clinic is 2000 square feet with long-term lease.
call center fields leads and sets appointments for the clinics.
Full training and ongoing corporate support are included.
